References
- Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by
transfusions in children with sickle cell anemia and abnormal results
on transcranial Doppler ultrasonography. N Engl J Med.1998;339(1):5-11.
- Aguilar-Salinas P, Hayward K, Santos R, et al. Surgical
Revascularization for Pediatric Patients with Sickle Cell Disease and
Moyamoya Disease in the Prevention of Ischemic Strokes: A
Single-Center Case Series and a Systematic Review. World
Neurosurg. 2019;123:435-442.e438.
- Bishop S, Matheus MG, Abboud MR, et al. Effect of chronic transfusion
therapy on progression of neurovascular pathology in pediatric
patients with sickle cell anemia. Blood Cells Mol Dis.2011;47(2):125-128.
- Crist WM, Garnsey L, Beltangady MS, et al. Prognosis in children with
rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies
I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol.1990;8(3):443-452.
- Dobson SR, Holden KR, Nietert PJ, et al. Moyamoya syndrome in
childhood sickle cell disease: a predictive factor for recurrent
cerebrovascular events. Blood. 2002;99(9):3144-3150.
- Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA. Sickle cell anemia
with moyamoya disease: outcomes after EDAS procedure. Pediatr
Neurol. 2003;29(2):124-130.
- Griessenauer CJ, Lebensburger JD, Chua MH, et al.
Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for
treatment of moyamoya syndrome in pediatric patients with sickle cell
disease. J Neurosurg Pediatr. 2015;16(1):64-73.
- Hall EM, Leonard J, Smith JL, et al. Reduction in Overt and Silent
Stroke Recurrence Rate Following Cerebral Revascularization Surgery in
Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.Pediatr Blood Cancer. 2016;63(8):1431-1437.
- Hankinson TC, Bohman LE, Heyer G, et al. Surgical treatment of
moyamoya syndrome in patients with sickle cell anemia: outcome
following encephaloduroarteriosynangiosis. J Neurosurg Pediatr.2008;1(3):211-216.
- Hasuo K, Mihara F, Matsushima T. MRI and MR angiography in moyamoya
disease. J Magn Reson Imaging. 1998;8(4):762-766.
- Helton KJ, Adams RJ, Kesler KL, et al. Magnetic resonance
imaging/angiography and transcranial Doppler velocities in sickle cell
anemia: results from the SWiTCH trial. Blood.2014;124(6):891-898.
- Kennedy BC, McDowell MM, Yang PH, et al. Pial synangiosis for moyamoya
syndrome in children with sickle cell anemia: a comprehensive review
of reported cases. Neurosurg Focus. 2014;36(1):E12.
- Lee MT, Piomelli S, Granger S, et al. Stroke Prevention Trial in
Sickle Cell Anemia (STOP): extended follow-up and final results.Blood. 2006;108(3):847-852.
- Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular
accidents in sickle cell disease: rates and risk factors.Blood. 1998;91(1):288-294.
- Russell MO, Goldberg HI, Hodson A, et al. Effect of transfusion
therapy on arteriographic abnormalities and on recurrence of stroke in
sickle cell disease. Blood. 1984;63(1):162-169.
- Smith ER, McClain CD, Heeney M, Scott RM. Pial synangiosis in patients
with moyamoya syndrome and sickle cell anemia: perioperative
management and surgical outcome. Neurosurg Focus.2009;26(4):E10.
- Yang W, Xu R, Porras JL, et al. Effectiveness of surgical
revascularization for stroke prevention in pediatric patients with
sickle cell disease and moyamoya syndrome. J Neurosurg Pediatr.2017;20(3):232-238.